Fulgent Genetics Inc.(FLGT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FLGT Fulgent Genetics Inc.

已收盘 07-22 16:00:00 EDT

22.34

+0.52

+2.38%

盘后22.34

+0.000.00%

19:02 EDT

最高22.53	最低21.56	成交量14.25万
今开21.86	昨收21.82	日振幅4.45%
总市值6.69亿	流通市值4.42亿	总股本2,992万
成交额315.88万	换手率0.72%	流通股本1,980万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FLGT","market":"US","secType":"STK","nameCN":"Fulgent Genetics Inc.","latestPrice":22.34,"timestamp":1721678400000,"preClose":21.82,"halted":0,"volume":142471,"hourTrading":{"tag":"盘后","latestPrice":22.34,"preClose":22.34,"latestTime":"19:02 EDT","volume":4240,"amount":94714.65,"timestamp":1721689329025},"delay":0,"floatShares":19803783,"shares":29924288,"eps":-5.560807,"marketStatus":"已收盘","marketStatusCode":5,"change":0.52,"latestTime":"07-22 16:00:00 EDT","open":21.86,"high":22.53,"low":21.56,"amount":3158845.9262920003,"amplitude":0.044455,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.560807,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721721600000},"adr":0,"listingDate":1475121600000,"adjPreClose":21.82,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":22.34,"preClose":22.34,"latestTime":"19:02 EDT","volume":4240,"amount":94714.65,"timestamp":1721689329025},"volumeRatio":0.366389,"impliedVol":0.5494,"impliedVolPercentile":0.7809},"requestUrl":"/m/hq/s/FLGT/wiki","defaultTab":"wiki","newsList":[{"id":"2452019595","title":"Fulgent Genetics, Inc.盘中异动 股价大涨5.17%报23.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452019595","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452019595?lang=zh_cn&edition=full","pubTime":"2024-07-18 02:22","pubTimestamp":1721240552,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日02时22分，Fulgent Genetics, Inc.股票出现波动，股价快速上涨5.17%。截至发稿，该股报23.00美元/股，成交量43.0514万股，换手率1.44%，振幅5.99%。Fulgent Genetics, Inc.股票所在的生命科学行业中，整体跌幅为0.21%。Fulgent Genetics, Inc.公司简介：Fulgent Genetics Inc 是一家专注于基因检测的技术公司，为医生提供临床可操作的诊断信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718022232af92ce07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718022232af92ce07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FLGT","BK4196"],"gpt_icon":0},{"id":"2450036438","title":"Fulgent Genetics, Inc.盘中异动 早盘急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450036438","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450036438?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:52","pubTimestamp":1720709527,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时52分，Fulgent Genetics, Inc.股票出现波动，股价急速拉升5.00%。Fulgent Genetics, Inc.股票所在的生命科学行业中，整体涨幅为2.14%。其相关个股中，Inotiv, Inc.、Ispecimen Inc.、Caredx, Inc.涨幅较大，Ispecimen Inc.、Applied Dna Sciences, Inc.、Endra Life Sciences Inc.较为活跃，换手率分别为275.42%、3.70%、1.84%，振幅较大的相关个股有Ispecimen Inc.、Inotiv, Inc.、基因技术，振幅分别为96.89%、12.86%、12.35%。Fulgent Genetics, Inc.公司简介：Fulgent Genetics Inc 是一家专注于基因检测的技术公司，为医生提供临床可操作的诊断信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711225207af91e0cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711225207af91e0cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FLGT","BK4196"],"gpt_icon":0},{"id":"2432151720","title":"Fulgent Genetics Inc 报告截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432151720","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432151720?lang=zh_cn&edition=full","pubTime":"2024-05-04 07:28","pubTimestamp":1714778923,"startTime":"0","endTime":"0","summary":"   * Fulgent Genetics Inc   报告，截至3月底的季度调整后每股亏损1美分，高于去年同期的每股-22美分。三位分析师对该季度的平均预期是每股亏损 32 美分。华尔街预期为每股-35美分至-30美分。* Fulgent Genetics 公司公布的本季度每股收益为亏损 45 美分。* Fulgent Genetics Inc本季度股价下跌了2.1%，今年迄今为止下跌了26.5%。5月3日 - 预测变化   * 过去三个月，分析师的平均盈利预期下降了约 41.2%。华尔街对 Fulgent Genetics Inc 的 12 个月目标价中位数为 25.00 美元。本摘要由 LSEG 5 月 3 日 11:28 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLGT","BK4196"],"gpt_icon":0},{"id":"2432557076","title":"Fulgent Genetics Inc    预计每股亏损 32 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432557076","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432557076?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:54","pubTimestamp":1714571688,"startTime":"0","endTime":"0","summary":"   * Fulgent Genetics Inc    将于5月3日公布截至2024年3月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，3位分析师的平均预期是，这家总部位于加利福尼亚州艾尔蒙特的公司的营收将从去年同期的6617万美元下降1.2%，至6536.3万美元。* LSEG分析师对Fulgent Genetics公司的平均预期是每股亏损32美分。* 华尔街对 Fulgent Genetics Inc 的 12 个月目标价中位数为 25.00 美元，高于其上次收盘价 20.35 美元。5月1日 - 以前季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLGT"],"gpt_icon":0},{"id":"2431970618","title":"Fulgent Genetics, Inc.盘中异动 大幅拉升5.02%报21.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431970618","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431970618?lang=zh_cn&edition=full","pubTime":"2024-04-30 00:09","pubTimestamp":1714406988,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日00时09分，Fulgent Genetics, Inc.股票出现波动，股价快速上涨5.02%。Fulgent Genetics, Inc.股票所在的生命科学行业中，整体涨幅为1.20%。其相关个股中，Endra Life Sciences Inc.、23Andme Holding Co.、Neogenomics, Inc.涨幅较大，Applied Dna Sciences, Inc.、Ispecimen Inc.、奎斯特诊疗较为活跃，换手率分别为1.61%、1.09%、0.88%，振幅较大的相关个股有Endra Life Sciences Inc.、23Andme Holding Co.、Xwell, Inc.，振幅分别为22.69%、10.77%、10.47%。Fulgent Genetics, Inc.公司简介：Fulgent Genetics Inc 是一家专注于基因检测的技术公司，为医生提供临床可操作的诊断信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430000948861ea232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430000948861ea232&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","FLGT"],"gpt_icon":0},{"id":"2417239460","title":"美国研究综述-Arrivent 生物制药公司、弗格森公司、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2417239460","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417239460?lang=zh_cn&edition=full","pubTime":"2024-03-06 14:48","pubTimestamp":1709707680,"startTime":"0","endTime":"0","summary":"    路透社3月6日 - 华尔街证券分析师周三调整了对 Arrivent Biopharma、Ferguson 和 Target 等几家美国上市公司的评级和目标价。要闻             * Arrivent Biopharma Inc   ：杰富瑞给予买入评级             * 弗格森  ：杰富瑞将目标价从 222 美元上调至 244 美元             * Target Corp   ：汇丰银行将其评级从 \"持有 \"上调至 \"买入\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823414478.USD","SG","BOX","AGS","CTKB","LU1244550577.SGD","FWRG","LU0053666078.USD","LU2272731782.SGD","MCRB","STIM","MD","BK4588","LU0082616367.USD","BASE","NNN","LU0348723411.USD","NKTR","TSLA","AVBP","DYN","BK4585","NTRA","TRGP","VYX","PLAY","CRGY","BK4023","FERG","LU2272731600.USD","TWLO","LII","NWPX","APGE","ATIP","COLB","TGT","FLGT","HCP","JWN","AVAV","AXGN","BK4144","EHAB","NTST","IONS","LU0823411888.USD","LFST","ROST","CRWD"],"gpt_icon":0},{"id":"2414533855","title":"Fulgent Genetics Inc盘中异动 急速拉升5.11%报25.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414533855","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414533855?lang=zh_cn&edition=full","pubTime":"2024-02-28 04:55","pubTimestamp":1709067306,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日04时55分，Fulgent Genetics Inc股票出现异动，股价急速上涨5.11%。Fulgent Genetics Inc股票所在的生命科学行业中，整体涨幅为0.85%。其相关个股中，Bioaffinity Technologies Inc、Caredx Inc、Opko健康涨幅较大，Aclaris Therapeutics Inc、T2 Biosystems Inc、Inotiv Inc较为活跃，换手率分别为3.72%、3.19%、2.89%，振幅较大的相关个股有Centogene Nv、Sotera Health Co、Aclaris Therapeutics Inc，振幅分别为21.10%、16.88%、16.53%。Fulgent Genetics Inc公司简介：Fulgent Genetics Inc是一家专注于基因检测的科技公司，旨在为医生提供临床可操作的诊断信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402280455067a476075&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402280455067a476075&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FLGT","BK4196"],"gpt_icon":0},{"id":"2414838899","title":"Fulgent Genetics Inc    预计每股亏损 29 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414838899","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414838899?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:36","pubTimestamp":1708958182,"startTime":"0","endTime":"0","summary":"   * Fulgent Genetics Inc    将于2月28日公布截至2023年12月31日的财报，预计该公司的季度收入将出现下降。* 根据3位分析师基于LSEG数据的平均预期，这家总部位于加利福尼亚州埃尔蒙特市的公司预计营收将从去年同期的6770万美元下降2.0%至6632.2万美元。   * LSEG 的分析师平均预计 Fulgent Genetics 公司每股亏损 29 美分。* 华尔街对 Fulgent Genetics Inc 的 12 个月目标价中位数为 35.00 美元，高于其最新收盘价 24.06 美元。2月26日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLGT"],"gpt_icon":0},{"id":"2411938293","title":"Fulgent Genetics Inc盘中异动 快速下挫5.08%报24.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411938293","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411938293?lang=zh_cn&edition=full","pubTime":"2024-02-14 01:51","pubTimestamp":1707846675,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日01时51分，Fulgent Genetics Inc股票出现波动，股价急速跳水5.08%。截至发稿，该股报24.84美元/股，成交量4.8634万股，换手率0.16%，振幅2.33%。Fulgent Genetics Inc股票所在的生命科学行业中，整体跌幅为1.66%。Fulgent Genetics Inc公司简介：Fulgent Genetics Inc是一家专注于基因检测的科技公司，旨在为医生提供临床可操作的诊断信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021401511587e6ff1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021401511587e6ff1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FLGT","BK4196"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fulgentgenetics.com","stockEarnings":[{"period":"1week","weight":0.0415},{"period":"1month","weight":0.1031},{"period":"3month","weight":0.0717},{"period":"6month","weight":-0.1665},{"period":"1year","weight":-0.4576},{"period":"ytd","weight":-0.2452}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fulgent Genetics, Inc.在2016年5月13日注册成立于美国特拉华州。该公司是一家以技术为基础的公司，拥有成熟的临床诊断业务和治疗开发业务。该公司临床诊断业务提供分子诊断检测服务、全面的基因检测和高质量的解剖病理实验室服务，旨在为医生和患者提供临床可操作的诊断信息，以提高患者护理质量。该公司的治疗开发业务专注于使用新型纳米封装和靶向治疗平台开发治疗多种癌症的候选药物，该平台旨在改善新的和现有癌症药物的治疗窗口和药代动力学特征，或PK特征。该公司的目标是从基因组诊断业务转型为一家完全整合的精准医疗公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.147937},{"month":2,"riseRate":0.375,"avgChangeRate":-0.004993},{"month":3,"riseRate":0.25,"avgChangeRate":-0.035738},{"month":4,"riseRate":0.25,"avgChangeRate":0.019298},{"month":5,"riseRate":0.375,"avgChangeRate":-0.024642},{"month":6,"riseRate":0.625,"avgChangeRate":0.039903},{"month":7,"riseRate":0.75,"avgChangeRate":0.129564},{"month":8,"riseRate":0.285714,"avgChangeRate":0.018581},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.032387},{"month":10,"riseRate":0.125,"avgChangeRate":-0.08803},{"month":11,"riseRate":0.625,"avgChangeRate":0.099665},{"month":12,"riseRate":0.75,"avgChangeRate":0.061218}],"exchange":"NASDAQ","name":"Fulgent Genetics Inc.","nameEN":"Fulgent Genetics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fulgent Genetics Inc.(FLGT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fulgent Genetics Inc.(FLGT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fulgent Genetics Inc.,FLGT,Fulgent Genetics Inc.股票,Fulgent Genetics Inc.股票老虎,Fulgent Genetics Inc.股票老虎国际,Fulgent Genetics Inc.行情,Fulgent Genetics Inc.股票行情,Fulgent Genetics Inc.股价,Fulgent Genetics Inc.股市,Fulgent Genetics Inc.股票价格,Fulgent Genetics Inc.股票交易,Fulgent Genetics Inc.股票购买,Fulgent Genetics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fulgent Genetics Inc.(FLGT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fulgent Genetics Inc.(FLGT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}